HOLOGIC INC (HOLX)
US4364401012 - Common Stock
HOLX gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Health Care Equipment & Supplies industry. HOLX has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. HOLX has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year HOLX was profitable.
HOLX had a positive operating cash flow in the past year.
HOLX had positive earnings in each of the past 5 years.
Each year in the past 5 years HOLX had a positive operating cash flow.
1.2 Ratios
HOLX's Return On Assets of 8.62% is amongst the best of the industry. HOLX outperforms 90.48% of its industry peers.
HOLX has a Return On Equity of 15.39%. This is amongst the best in the industry. HOLX outperforms 90.48% of its industry peers.
Looking at the Return On Invested Capital, with a value of 9.48%, HOLX belongs to the top of the industry, outperforming 89.95% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for HOLX is above the industry average of 8.08%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | 15.39% | ||
| ROIC | 9.48% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
1.3 Margins
With an excellent Profit Margin value of 19.59%, HOLX belongs to the best of the industry, outperforming 93.12% of the companies in the same industry.
HOLX's Profit Margin has declined in the last couple of years.
The Operating Margin of HOLX (24.07%) is better than 94.71% of its industry peers.
HOLX's Operating Margin has improved in the last couple of years.
HOLX has a Gross Margin (56.25%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of HOLX has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 24.07% | ||
| PM (TTM) | 19.59% | ||
| GM | 56.25% |
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
2. Health
2.1 Basic Checks
HOLX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, HOLX has less shares outstanding
Compared to 5 years ago, HOLX has less shares outstanding
The debt/assets ratio for HOLX has been reduced compared to a year ago.
2.2 Solvency
An Altman-Z score of 3.96 indicates that HOLX is not in any danger for bankruptcy at the moment.
HOLX has a Altman-Z score of 3.96. This is in the better half of the industry: HOLX outperforms 71.96% of its industry peers.
HOLX has a debt to FCF ratio of 2.23. This is a good value and a sign of high solvency as HOLX would need 2.23 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 2.23, HOLX belongs to the best of the industry, outperforming 86.77% of the companies in the same industry.
HOLX has a Debt/Equity ratio of 0.49. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of HOLX (0.49) is worse than 60.85% of its industry peers.
Although HOLX does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 2.23 | ||
| Altman-Z | 3.96 |
ROIC/WACC1.08
WACC8.77%
2.3 Liquidity
A Current Ratio of 3.69 indicates that HOLX has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.69, HOLX is in the better half of the industry, outperforming 67.72% of the companies in the same industry.
A Quick Ratio of 3.03 indicates that HOLX has no problem at all paying its short term obligations.
The Quick ratio of HOLX (3.03) is better than 65.08% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.03 |
3. Growth
3.1 Past
HOLX shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.29%.
HOLX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 10.83% yearly.
Looking at the last year, HOLX shows a decrease in Revenue. The Revenue has decreased by 0.00% in the last year.
The Revenue has been growing slightly by 3.66% on average over the past years.
EPS 1Y (TTM)3.29%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%13.48%
Revenue 1Y (TTM)0%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%4.51%
3.2 Future
HOLX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.85% yearly.
HOLX is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.49% yearly.
EPS Next Y6.48%
EPS Next 2Y8.3%
EPS Next 3Y9.11%
EPS Next 5Y5.85%
Revenue Next Year3.61%
Revenue Next 2Y4.67%
Revenue Next 3Y5.09%
Revenue Next 5Y4.49%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 16.98 indicates a correct valuation of HOLX.
89.42% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 27.28, HOLX is valued a bit cheaper.
HOLX is valuated correctly with a Price/Forward Earnings ratio of 15.94.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 87.83% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 23.53. HOLX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.98 | ||
| Fwd PE | 15.94 |
4.2 Price Multiples
88.89% of the companies in the same industry are more expensive than HOLX, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 94.18% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.73 | ||
| EV/EBITDA | 12.49 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)2.62
PEG (5Y)1.57
EPS Next 2Y8.3%
EPS Next 3Y9.11%
5. Dividend
5.1 Amount
HOLX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
HOLOGIC INC
NASDAQ:HOLX (1/15/2025, 11:37:19 AM)
69.27
-0.93 (-1.32%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners100.25%
Inst Owner Change0.23%
Ins Owners0.71%
Ins Owner Change3.08%
Market Cap15.72B
Analysts73.57
Price Target88.53 (27.8%)
Short Float %2.45%
Short Ratio2.59
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.02%
Min EPS beat(2)-2.26%
Max EPS beat(2)2.31%
EPS beat(4)3
Avg EPS beat(4)1.09%
Min EPS beat(4)-2.26%
Max EPS beat(4)3.3%
EPS beat(8)7
Avg EPS beat(8)5.47%
EPS beat(12)11
Avg EPS beat(12)16.37%
EPS beat(16)14
Avg EPS beat(16)18.5%
Revenue beat(2)0
Avg Revenue beat(2)-0.84%
Min Revenue beat(2)-0.84%
Max Revenue beat(2)-0.84%
Revenue beat(4)1
Avg Revenue beat(4)-0.35%
Min Revenue beat(4)-0.84%
Max Revenue beat(4)0.71%
Revenue beat(8)4
Avg Revenue beat(8)0.9%
Revenue beat(12)8
Avg Revenue beat(12)4.59%
Revenue beat(16)11
Avg Revenue beat(16)6.22%
PT rev (1m)-2.56%
PT rev (3m)-1.77%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.81%
EPS NY rev (1m)-0.36%
EPS NY rev (3m)-3.95%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.78%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-1.58%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.98 | ||
| Fwd PE | 15.94 | ||
| P/S | 3.9 | ||
| P/FCF | 13.73 | ||
| P/OCF | 12.23 | ||
| P/B | 3.06 | ||
| P/tB | 18.66 | ||
| EV/EBITDA | 12.49 |
EPS(TTM)4.08
EY5.89%
EPS(NY)4.34
Fwd EY6.27%
FCF(TTM)5.05
FCFY7.28%
OCF(TTM)5.66
OCFY8.18%
SpS17.76
BVpS22.61
TBVpS3.71
PEG (NY)2.62
PEG (5Y)1.57
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.62% | ||
| ROE | 15.39% | ||
| ROCE | 11.95% | ||
| ROIC | 9.48% | ||
| ROICexc | 13.31% | ||
| ROICexgc | 51.41% | ||
| OM | 24.07% | ||
| PM (TTM) | 19.59% | ||
| GM | 56.25% | ||
| FCFM | 28.41% |
ROA(3y)9.32%
ROA(5y)12.89%
ROE(3y)17.06%
ROE(5y)27.35%
ROIC(3y)11.66%
ROIC(5y)15.25%
ROICexc(3y)16.74%
ROICexc(5y)19.65%
ROICexgc(3y)75.27%
ROICexgc(5y)85.91%
ROCE(3y)14.69%
ROCE(5y)19.22%
ROICexcg growth 3Y-27.14%
ROICexcg growth 5Y-3.18%
ROICexc growth 3Y-24.3%
ROICexc growth 5Y7.08%
OM growth 3Y-18.26%
OM growth 5Y7.36%
PM growth 3Y-16.15%
PM growth 5YN/A
GM growth 3Y-5.85%
GM growth 5Y1.6%
F-Score8
Asset Turnover0.44
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.49 | ||
| Debt/FCF | 2.23 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 45.37% | ||
| Cap/Sales | 3.48% | ||
| Interest Coverage | 8.29 | ||
| Cash Conversion | 100.47% | ||
| Profit Quality | 145.03% | ||
| Current Ratio | 3.69 | ||
| Quick Ratio | 3.03 | ||
| Altman-Z | 3.96 |
F-Score8
WACC8.77%
ROIC/WACC1.08
Cap/Depr(3y)40.46%
Cap/Depr(5y)40.59%
Cap/Sales(3y)3.27%
Cap/Sales(5y)3.37%
Profit Quality(3y)165.37%
Profit Quality(5y)135.66%
High Growth Momentum
Growth
EPS 1Y (TTM)3.29%
EPS 3Y-21.36%
EPS 5Y10.83%
EPS Q2Q%13.48%
EPS Next Y6.48%
EPS Next 2Y8.3%
EPS Next 3Y9.11%
EPS Next 5Y5.85%
Revenue 1Y (TTM)0%
Revenue growth 3Y-10.56%
Revenue growth 5Y3.66%
Sales Q2Q%4.51%
Revenue Next Year3.61%
Revenue Next 2Y4.67%
Revenue Next 3Y5.09%
Revenue Next 5Y4.49%
EBIT growth 1Y3.09%
EBIT growth 3Y-26.89%
EBIT growth 5Y11.29%
EBIT Next Year17.57%
EBIT Next 3Y10.06%
EBIT Next 5Y9.03%
FCF growth 1Y27.08%
FCF growth 3Y-19.16%
FCF growth 5Y16.4%
OCF growth 1Y22.26%
OCF growth 3Y-17.99%
OCF growth 5Y14.62%